SOME ASPECTS OF APOPTOSIS IN HIGH ONCOGENIC RISK VIRAL INFECTIONS
- Autores: IVANOVA M.R1, KHARAYEVA Z.F1
-
Afiliações:
- Kh.M. Berbekov Kabardino-Balkar State University
- Edição: Nº 2 (2012)
- Páginas: 32-35
- Seção: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/275632
- ID: 275632
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The paper gives the data of an investigation of a cell receptor phenotype in chronic high oncogenic risk viral infections. The expressions of CD95 and TRAIL receptors in the peripheral blood leukocytes of patients with chronic viral hepatitis and those in the leukocytes and cellular elements of the cervical canal of women with papillomavirus infection were determined. The patients with chronic viral hepatitis showed a significant increase in the expressions of CD95 and TRAIL and those with high-oncogenic risk papillomavirus infection displayed their reduction, which suggests that there are various mechanisms to maintain their pathogenic potential for different viruses.
Palavras-chave
Texto integral
Sobre autores
M. IVANOVA
Kh.M. Berbekov Kabardino-Balkar State University
Email: marina19692003@list.ru
Nalchik
Z. KHARAYEVA
Kh.M. Berbekov Kabardino-Balkar State UniversityNalchik
Bibliografia
- Dbaibo G., Hannun J. Molecule of the month. Cytokine response modifier A: a strategically deployed viral weapon. Clin. Immunol. Immunopathol. 1998; 86 (2): 134—140.
- Ehrmann J.Jr., Galuszkova D., Ehrmann J. et al. Apoptosisrelated proteins Bcl-2, Bax, Fas, Fas-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection. Pathol. Oncol. Res. 2000; 6 (2): 130-135.
- Hay S., Kannourakis G. A time to kill: viral manipulation of the cell death program. J. Gen. Virol. 2002; 83: 1547-1564.
- Уткин О.В., Лебедев М.Ю., Новиков Д.В. и др. Изучение Материалы науч. конференции, посвященной 85-летию со дня рождения академика РАМН И.Н. Блохиной. Н. Новгород: ННГУ им. Н.И.Лобачевского, 2006: 202-206.
- Митрикова Л.Ц. Растворимый Fas-антиген в сыворотке крови больных острым гепатитом В. Эпидемиол. и инфекц. бол. 2003; 3: 34-36.
- Werner A.B., Vries E., Tait S.W.G. et al. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid. J. Biol. Chem. 2002; 277: 40760-40767.
- Lian-Jun Y., Wen-Liang W. Expression of Bcl-2 and Bax proteins in hepatocellular carcinoma tissue. J. Fourth. Mil. Med. Univ. 2002; 23: 337-340.
- Hardwick J.M. Virus-induced apoptosis. Adv. Pharmacol. 1997; 41: 295-336.
- Новицкий В.В., Рязанцева Н.В., Жукова О.Б. Молекулярные основы дизрегуляции программированной гибели лимфоцитов при хронической вирусной инфекции. Бюл. сибирской медицины 2006; 2: 23-34.
- Yoo Y.G., Lee M.O. Hepatitis B virus X protein induces expression of fas ligand gene through enhancing transcriptional activity of early growth response factor. J. Biol. Chem. 2004; 279 (35): 36242-36249.
- Gong-Ying Chen, Jian-Qin He, Guo-Cai Lu et al. Association between TRAIL expression on peripheral blood lymphocytes and liver damage in chronic hepatitis B. Wld J. Gastroenterol. 2005; 11 (26): 4090-4093.
- Du J. et al. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Cell Death and Differentiation website (http://www.nature.com/cdd)
Arquivos suplementares
